Inventor · Hanover, NH, US

Ethan Dmitrovsky

22Patents
2h-index
22Co-inventors
57Inventor score

Filing activity: Jul 21, 1993 → Jul 7, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8417324B2 Fluorescence lifetime spectrometer (FLS) and methods of detecting diseased tissue Physics 16 Active
US5843642A Methods for detection of acute promyelocytic leukemia (APL) Emerging Cross-Sectional Technologies 3 Expired
US10201512B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 2 Active
US7955848B2 MicroRNA biomarkers for human breast and lung cancer Chemistry; Metallurgy 2 Active
US11166927B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 1 Active
US8283113B2 Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG15 and/or UBP43 Chemistry; Metallurgy 1 Active
US8068898B2 Fluorescence lifetime spectrometer (FLS) and methods of detecting diseased tissues Physics 1 Expired
US10034845B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 1 Active
US10285960B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 0 Active
US11246845B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 0 Active
US9056135B2 MicroRNA biomarkers for human breast and lung cancer Chemistry; Metallurgy 0 Active
US8124371B2 Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation Physics 0 Active
US8207325B2 MicroRNA biomarkers for human breast and lung cancer Chemistry; Metallurgy 0 Active
US10945976B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 0 Active
US10695307B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 0 Active
US11547684B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 0 Active
US10653650B2 Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists Human Necessities 0 Active
US11576881B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 0 Active
US7586022B2 Transgenic non-human animal model of lung tumorigenesis Chemistry; Metallurgy 0 Active
US12383521B2 Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists Human Necessities 0 Active
US11793781B2 Autoimmune disorder treatment using RXR agonists Emerging Cross-Sectional Technologies 0 Active
US8697668B2 Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG215 and/or UBP43 Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.